COPD

Treatable traits associated with the decline in lung function and quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD) were detected in a longitudinal study, highlighting targets that physicians can address to better individualize COPD management.

Variances between sex and age were found among patients with chronic obstructive pulmonary disease (COPD) with a viral infection who visited the emergency department (ED) visit or were hospitalized, highlighting the role that these factors play.

Physical frailty affects a large proportion of patients with chronic obstructive pulmonary disease (COPD) and chronic respiratory failure and current tools for detection may be inadequate, according to a recent report.

Abstracts from the ATS 2021 International Conference addressed patient decision-making frameworks for seeking care for chronic obstructive pulmonary disease (COPD) and tactics used to assist hospitals in implementing readmission reduction plans.

Abstracts from the ATS 2021 International Conference provided some insight into tactics that could improve the effectiveness of pulmonary rehabilitation programs in patients with chronic obstructive pulmonary disease (COPD).

Posters presented at the ATS 2021 International Conference noted some ways clinical characteristics associated with patients with chronic obstructive pulmonary disease (COPD) differ based on different demographics and smoking status.

In a review, investigators concluded that physicians should use pulmonary function tests in addition to standard spirometry evaluations to better ensure that patients are appropriately being diagnosed and treated for chronic obstructive pulmonary disease (COPD).

The model that incorporated environmental and lifestyle data collected from a fitness tracker and a smartphone app was successful at predicting acute exacerbation of chronic obstructive pulmonary disease (AECOPD) 7 days in advance.

Although most Medicare Part D plans cover guideline-recommended outpatient chronic obstructive pulmonary disease (COPD) inhalers, the utilization controls applied to these therapies vary by plan type.

Specific factors, such as experience with technology and health literacy, were key drivers of whether a patient with chronic obstructive pulmonary disease (COPD) would benefit or be likely to use eHealth tools to improve self-management skills, investigators concluded.

Factors related to pulmonary and physical activity could serve as predictors for how long patients with chronic obstructive pulmonary disease (COPD) can tolerate during an endurance walk test, potentially leading to more accurate analyses on the effectiveness of interventions.

Growth differentiation factor 11 (GDF11) may be a useful biomarker for predicting physical activity in patients with chronic obstructive pulmonary disease (COPD), which could help physicians better determine disease prognosis, investigators concluded.

Authors of a global meta-analysis concluded that patients with chronic obstructive pulmonary disease (COPD), who are generally at a higher risk for lung cancer, may gain some protection from inhaled corticosteroids.

Investigators explored common challenges cited by hospital staff as barriers to implementation and adherence with national guidelines for managing chronic obstructive pulmonary disease (COPD).

Investigators concluded that patients with prior pulmonary tuberculosis had an increased risk and high prevalence of chronic obstructive pulmonary disease (COPD), regardless of smoking history.

Investigators found a potential link between chronic obstructive pulmonary disease (COPD) and greater risk of experiencing stroke and myocardial infarction in patients with hypertension.

Nicola Hanania, MD, MS, explains how some patients with chronic obstructive pulmonary disease (COPD) face challenges when it comes to affording treatment for the disease.

A meta-analysis, where many studies ranged in evidence quality, revealed mixed results on the effectiveness of blended self-management interventions in chronic lung conditions, establishing a need for more research.

Patients with chronic obstructive pulmonary disease (COPD) were found to be more likely to take medications for depression or anxiety than for other common comorbidities associated with the disease, investigators concluded.

A quality assessment program conducted in the Republic of Korea may be effective in improving disease management and prognosis for patients with chronic obstructive pulmonary disease (COPD), but the effects may be temporary.

Two therapeutic regimens used for the treatment of chronic obstructive pulmonary disease (COPD) are rarely being prescribed to patients without a COPD diagnosis, investigators concluded.

Largely driven by hospitalizations and medications, health care costs were found to be 3 times greater for patients with chronic obstructive pulmonary disease (COPD) than for healthy individuals, according to a recent Danish study.

A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life.

Patients with chronic obstructive pulmonary disease (COPD) with clinically important deterioration were found to have greater exacerbations and mortality risks; however, triplet therapy could help rectify that.

After Medicare Part D plans stopped covering a chronic obstructive pulmonary disease (COPD) therapy, patients had gaps in care and increased out-of-pocket costs, according to a recent study.

Researchers analyzed 2 cohorts of patients with chronic obstructive pulmonary disease (COPD) to characterize who is most at risk for developing hypercapnia and who could most benefit from at-home noninvasive inhalation therapy.

Telerehabilitation programs for chronic obstructive pulmonary disease (COPD) have to address uptake barriers surrounding inadequate funding and access issues for elderly patients in order to last in a post–COVID-19 world, according to researchers.

Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids plus bronchodilators.

Researchers found that thousands of patients with chronic obstructive pulmonary disease (COPD) did not follow the traditional trajectory associated with the disease, suggesting a possible incorrect diagnosis.

Results from the AIRFLOW-1 study demonstrate that targeted lung denervation did not produce any severe adverse reactions in patients with chronic obstructive pulmonary disease (COPD) after 3 years.